Physician profile
Max Gerald Garoutte
NPI 1235135344
$13,020.14
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,105 · 2020: $2,220 · 2021: $933 · 2022: $763.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $10,575.18 | 2019-2020 | |
| Abbott Laboratories | $1,949.99 | 2019-2022 | |
| Medtronic, INC. | $283.79 | 2021-2022 | |
| Philips North America LLC | $100.20 | 2020 | |
| Medtronic Vascular, INC. | $75.35 | 2020 | |
| Osprey Medical INC | $19.48 | 2021 | |
| Biotronik INC. | $16.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Garoutte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.